ANEBAnebulo Pharmaceuticals Inc

$0.4388
$0.0487
(12.48%)
Today
Updated: 09:50 AM EDT
Reported EarningsFeb 12
Mkt Cap$15.91M
Vol112.00
News
all
press releases
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the Company or...
Business Wire
News Placeholder
More News
News Placeholder
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the Company or...
Business Wire
News Placeholder
Anebulo Pharmaceuticals Announces Final Results of Tender Offer
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the Company or...
Business Wire
News Placeholder
Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the Company or...
Business Wire
News Placeholder
How Is The Market Feeling About Anebulo Pharmaceuticals Inc?
read more...
Benzinga
News Placeholder
Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the Company or...
Business Wire
News Placeholder
Anebulo Pharmaceuticals (NASDAQ:ANEB) Trading 0.8% Higher - Still a Buy?
Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Up 0.8% - Here's Why...
MarketBeat
News Placeholder
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the Company or...
Business Wire
<
...
1
>

Advertisement|Remove ads.